Nationwide Class For Vioxx Suit Rejected

Law360, New York (September 6, 2007, 12:00 AM EDT) -- Handing Merck & Co. a victory, the New Jersey Supreme Court on Thursday reversed a lower court ruling that certified a nationwide class of Vioxx consumers attempting to get back the money they spent on the drug.

The supreme court cited two reasons for rejecting the certification of a nationwide class of insurance companies and other third-parties. The claims of the third-party payors involved different questions of fact or law, and a class action in this case would not be superior to other available methods of...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.